Researchers
Jevtić, Bojan
Results 1-20 of 55
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | Eksperimentalni autoimunski encefalomijelitis indukovan u DA pacova bez korišćenja adjuvansa kao model multiple skleroze | Stanisavljević, Suzana | Conference Paper | Mp. category will be shown later |
| 2026 | Imunske ćelije pluća imaju aktivnu ulogu u patogenezi autoimunosti usmerene protiv centralnog nervnog sistema | Stegnjaić, Goran | Other | Mp. category will be shown later |
| 2026 | Minociklin ostvaruje antiencefalitogeno dejstvo ograničavajući CD4+CD11bc+ ćelije | Milosavljević, Zorana | Conference Paper | Mp. category will be shown later |
| 2026 | Changes in Adaptive Immunity in Autoimmune Diseases and Aging: Shared Features, Key Differences, and Implications for Immune Vulnerability | Jevtić, Bojan | Reviews | 21M21 |
| 2025 | Amelioration of Central Nervous System Autoimmunity Through FFAR2 Agonism Is Associated With Changes in Gut Microbiota | Jevtić, Bojan | Article | 21M21 |
| 2025 | Connecting brain and gut inflammation in the murine model of Alzheimer’s disease | Mićanović, Dragica | Conference Paper | Mp. category will be shown later |
| 2025 | Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor![]() | Jevtić, Bojan | Article | 21M21 |
| 2025 | Vaccine-Induced Humoral and Cellular Response to SARS-CoV-2 in Multiple Sclerosis Patients on Ocrelizumab![]() | Drulović, Jelena | Article | 21M21 |
| 2024 | ILC3 stimulation by a novel FFAR2 agonist ameliorates type 1 diabetes in C57BL/6 mice![]() | Koprivica, Ivan | Conference Paper | Mp. category will be shown later |
| 2024 | Brain inflammation in experimental autoimmune encephalomyelitis induced in Dark Agouti rats with spinal cord homogenate | Stegnjaić, Goran | Article | 22M22 |
| 2024 | Pharmacological activation of free fatty acid receptor 2 in intestinal type 3 innate lymphoid cells ameliorates experimental autoimmune encephalomyelitis | Lazarević, Milica | Conference Paper | Mp. category will be shown later |
| 2024 | Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity![]() | Lazarević, Milica | Article | 21a+M21a+ |
| 2024 | Phenethyl ester of rosmarinic acid ameliorates acute respiratory distress syndrome | Marković, Maša | Conference Paper | Mp. category will be shown later |
| 2024 | Ethyl pyruvate ameliorates acute respiratory distress syndrome in mice![]() | Mićanović, Dragica | Article | 21aM21a |
| 2024 | Investigation of brain inflammation in complete Freund’s’ adjuvant-free experimental autoimmune encephalomyelitis![]() | Stanisavljević, Suzana | Conference Paper | Mp. category will be shown later |
| 2024 | NRF2 plays a crucial role in the tolerogenic effect of ethyl pyruvate on dendritic cells![]() | Stanisavljević, Suzana | Article | 21M21 |
| 2024 | Novel FFAR2 agonist prevents development of type 1 diabetes in C57BL/6 mice | Jonić, Natalija | Conference Paper | Mp. category will be shown later |
| 2023 | Molecular biomarkers as a prognostic tool for clinical courses of experimental autoimmune encephalomyelitis in rats immunized with spinal cord homogenate | Stegnjaić, Goran | Conference Paper | Mp. category will be shown later |
| 2023 | ILC3: a case of conflicted identity | Koprivica, Ivan | Article | 21M21 |
| 2023 | Development of Type 1 Diabetes in Mice Is Associated with a Decrease in IL-2-Producing ILC3 and FoxP3+ Treg in the Small Intestine![]() | Saksida, Tamara | Article | 21M21 |
